Advertisement
Person › Details
Bernd Mühlenweg (Nanobiotix S.A. (Euronext Paris: NANO, Nasdaq: NBTX))
Mühlenweg, Bernd (Nanobiotix 2011– Head Business Development before 2001–2011 Head BusDev at Wilex AG)
Organisation | Nanobiotix S.A. (Euronext Paris: NANO, Nasdaq: NBTX) | |
Group | Nanobiotix (Group) | |
Former/major organisation | Wilex AG | |
Today | Heidelberg Pharma AG (FSE: HPHA) | |
Group | Heidelberg Pharma (Group) | |
Product | nanobiotechnology | |
Product 2 | oncology | |
Record changed: 2015-08-27 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top